223 related articles for article (PubMed ID: 34841716)
1. Baicalein resensitizes tamoxifen-resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia-inducible factor-1α.
Chen Y; Zhang J; Zhang M; Song Y; Zhang Y; Fan S; Ren S; Fu L; Zhang N; Hui H; Shen X
Clin Transl Med; 2021 Nov; 11(11):e577. PubMed ID: 34841716
[TBL] [Abstract][Full Text] [Related]
2. GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells.
Zhang Y; Song Y; Ren S; Zhang M; Zhang Z; Fan S; Liu X; Peng X; Qi Q; Shen X; Chen Y
Oncogene; 2023 Jan; 42(3):184-197. PubMed ID: 36400971
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
[TBL] [Abstract][Full Text] [Related]
4. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
[TBL] [Abstract][Full Text] [Related]
5. Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1α signaling pathway.
Chen F; Zhuang M; Zhong C; Peng J; Wang X; Li J; Chen Z; Huang Y
Oncol Rep; 2015 Jan; 33(1):457-63. PubMed ID: 25333894
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study.
Collin LJ; Maliniak ML; Cronin-Fenton DP; Ahern TP; Christensen KB; Ulrichsen SP; Damkier P; Hamilton-Dutoit S; Yacoub R; Christiansen PM; Sørensen HT; Lash TL
Breast Cancer Res; 2021 Nov; 23(1):103. PubMed ID: 34736510
[TBL] [Abstract][Full Text] [Related]
7. Baicalein induces functional hypoxia-inducible factor-1alpha and angiogenesis.
Cho H; Lee HY; Ahn DR; Kim SY; Kim S; Lee KB; Lee YM; Park H; Yang EG
Mol Pharmacol; 2008 Jul; 74(1):70-81. PubMed ID: 18426858
[TBL] [Abstract][Full Text] [Related]
8. Baicalein protects against retinal ischemia by antioxidation, antiapoptosis, downregulation of HIF-1α, VEGF, and MMP-9 and upregulation of HO-1.
Chao HM; Chuang MJ; Liu JH; Liu XQ; Ho LK; Pan WH; Zhang XM; Liu CM; Tsai SK; Kong CW; Lee SD; Chen MM; Chao FP
J Ocul Pharmacol Ther; 2013; 29(6):539-49. PubMed ID: 23537149
[TBL] [Abstract][Full Text] [Related]
9. PRKAR2B-HIF-1α loop promotes aerobic glycolysis and tumour growth in prostate cancer.
Xia L; Sun J; Xie S; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Sha J; Xue W
Cell Prolif; 2020 Nov; 53(11):e12918. PubMed ID: 33025691
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Inhibition of MCT4 Reduces 4-Hydroxytamoxifen Sensitivity by Increasing HIF-1α Protein Expression in ER-Positive MCF-7 Breast Cancer Cells.
Nadai T; Narumi K; Furugen A; Saito Y; Iseki K; Kobayashi M
Biol Pharm Bull; 2021; 44(9):1247-1253. PubMed ID: 34471053
[TBL] [Abstract][Full Text] [Related]
11. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
[TBL] [Abstract][Full Text] [Related]
12. Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer.
Jögi A; Ehinger A; Hartman L; Alkner S
PLoS One; 2019; 14(12):e0226150. PubMed ID: 31821370
[TBL] [Abstract][Full Text] [Related]
13. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
Ai Z; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
[TBL] [Abstract][Full Text] [Related]
14. Nonylphenol inhibited HIF-1alpha regulated aerobic glycolysis and induced ROS mediated apoptosis in rat Sertoli cells.
Jiang Q; Di Q; Shan D; Xu Q
Ecotoxicol Environ Saf; 2022 Aug; 241():113822. PubMed ID: 35777343
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.
Maher JC; Wangpaichitr M; Savaraj N; Kurtoglu M; Lampidis TJ
Mol Cancer Ther; 2007 Feb; 6(2):732-41. PubMed ID: 17308069
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
[TBL] [Abstract][Full Text] [Related]
17. USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis.
Gao S; Wang Y; Xu Y; Liu L; Liu S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167011. PubMed ID: 38176460
[TBL] [Abstract][Full Text] [Related]
18. Cetuximab reverses the Warburg effect by inhibiting HIF-1-regulated LDH-A.
Lu H; Li X; Luo Z; Liu J; Fan Z
Mol Cancer Ther; 2013 Oct; 12(10):2187-99. PubMed ID: 23920275
[TBL] [Abstract][Full Text] [Related]
19. Balanophorin B inhibited glycolysis with the involvement of HIF-1α.
Dai T; Li L; Qi W; Liu B; Jiang Z; Song J; Hua H
Life Sci; 2021 Feb; 267():118910. PubMed ID: 33359671
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics.
Song Y; Ren S; Chen X; Li X; Chen L; Zhao S; Zhang Y; Shen X; Chen Y
Cancer Lett; 2024 May; 590():216847. PubMed ID: 38583647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
